Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.15% | 285.51 | 1.5% | $886.84m | |
| MRNA | Moderna, Inc. | 0.48% | 182.35 | 0.0% | $766.05m | |
| GILD | Gilead Sciences, Inc. | 1.29% | 89.03 | 1.0% | $711.02m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.68% | 766.39 | 2.6% | $519.32m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.19% | 321.37 | 1.9% | $493.66m | |
| BIIB | Biogen, Inc. | -0.98% | 298.90 | 1.8% | $408.64m | |
| ILMN | Illumina, Inc. | -0.95% | 218.76 | 3.2% | $260.35m | |
| BNTX | BioNTech SE | 0.16% | 169.74 | 0.0% | $177.87m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.47% | 105.56 | 4.2% | $171.26m | |
| AXSM | Axsome Therapeutics, Inc. | 6.85% | 76.90 | 1.6% | $154.62m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -5.78% | 2.12 | 0.7% | $148.20m | |
| MRTX | Mirati Therapeutics, Inc. | 5.19% | 96.25 | 1.6% | $147.31m | |
| HALO | Halozyme Therapeutics, Inc. | 3.55% | 59.44 | 18.4% | $81.17m | |
| NVAX | Novavax, Inc. | -1.96% | 16.52 | 75.3% | $77.50m | |
| IMGO | Imago BioSciences, Inc. | 0.03% | 35.73 | 0.0% | $57.06m |
Company Profile
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.